Objective: Adherence to Anti-Retroviral Therapy is a principal predictor for the success of Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) treatment. It remains as a challenge to AIDS treatment and care with the wide spread of the associated risks. The study aims to assess adherence level and factors associated with adherence to Anti-Retroviral Therapy (ART) among people living with HIV and AIDS in Far West, Nepal.
Introduction
I t is estimated that 4.7 million people in Asia are living with Human Immunodeficiency Virus (HIV), including 3, 50,000 who became newly infected last year. 1 Asia's epidemic peaked in the mid-1990s, and
annual HIV incidence has subsequently declined by more than half. In 2008, an estimated 3, 30,000 AIDS-related deaths occurred in Asia. While the annual number of AIDS-related deaths in South and South-East Asia in 2008 was approximately 12%. 2 In the 1990s, Introduction of Anti Retro Virals (ARVs) brought new hope to people living with HIV. More recently, the increased availability of treatment has dramatically improved survival rates and lowered the incidence of opportunistic infections in people with AIDS. that as HIV and AIDS is a rapidly evolving medical field. It helps for the rationale use of the drugs. Till date there are 23 ART sites where 3,423 patients are on treatment. 6 The ARV logistic system in Nepal is managed by NCASC itself with minimal co-ordination with Logistic Management Division (LMD).
Far West Hills, with one of Asia's fastest growing AIDS epidemics, account for the 16% of total HIV infections. 4 Eligible altogether 565 Patients are on the treatment from four ART sites viz. Seti Zonal Hospital, Mahakali Zonal Hospital, Doti District Hospital and Achham District Hospital. 6 The high migration rate (at least one male member from 80-90% of the household) has contributed for the rapid spread of HIV/AIDS. About 10% of the migrants returning from Mumbai, India have been tested HIV positive. 6 To ensure the treatment is progressed, adherence of patient on ART is critical. Adherence means a more collaborative process between the patient and provider. It is the act of following a course of medication in exactly the manner it is prescribed. 7 Adherence to Anti-Retroviral Therapy (ART)
is second largest predictor of progression to AIDS and death after CD4 count/reduced HIV RNA replication. 8 In ART, adherence is essential for successful treatment and sustained viral control. To achieve treatment success requires near-perfect adherence to combination ARV regimens. Adherence to an ARV treatment regimen involves taking all pills in the correctly prescribed doses, at the right time, and in the right way. 9 Studies indicate that more than 95% of the doses should be taken for optimal suppression 11 .The lesser degree of adherence is more often associated with the virological failure. Poor adherence is linked with the likelihood of the drug resistance and direct treatment failure.
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The Second-line ART is the next regimen used in sequence immediately after first-line therapy has failed (clinically, and or immunologically and or virologically). 10 Failure to first line ART is also a growing concern in Nepal with already eight cases registered on the 2 nd line ART. 6 The risk of transmission of resistant viruses and limited future treatment options due to poor adherence makes adherence a public health concern. The aim of the study is to calculate adherence rate and to determine the factors associated to Adherence to Anti-Retroviral Therapy (ART) among People Living with HIV and AIDS in FarWest, Nepal.
Material and Methods
A cross sectional study was carried out using both quantitative and qualitative methods to identify magnitude of adherence; and protective and risk factors to adherence to ART among HIV infected persons. The semi structured self report questionnaire schedule from Adults AIDS Clinical Trial Group (AACTG) was modified to cultural context then translated in Nepali and pre tested. 5 Study was conducted in Far West, Nepal from
May to September 2009 in all four ART sites. Patients of age above 15 years and taking ARVs for at least 3 months were enrolled in the study. 13, 19 Data were collected on the basis of patient self report except CD4 count which was taken from medical record.
A total of 176 samples allowed with 95% CI and 5% error proportionately from four ART sites were drawn by using formula for estimation of sample size, n = Z 2 pqN / α 2 (N- 
Results

Baseline characteristics
A total 176 patients consented and participated in the study, of which 156 records (n=156) were analyzed. Twenty records were excluded for incompleteness. This represents 88.6% of the number of patients eligible for the study. A total of 73 males and 83 females participated in the study. The mean age was 37 years with the minimum 24 and maximum 62 with the standard deviation of 7.7. There were a high proportion of patients from urban (69%) locations compared to rural (31%) with having highest number of patients from Dalit ethnicity of 69 (44%).
Adherence to the treatment
About 17% of patients delayed more than 1 hour to take the pills and 3% have missed to take the drugs during the last week with adherence rate 97.4%. A total of 32 patients have missed to take at least single pill within the last month. Eighty four percent of the participants had more than 95% adherence and 16% respondents were less than the optimum adherence (i.e. 9% for 80-95% and 7% for < 80%), accounting for the 84% adherence rate within the last month.
Associated factors
Among the patients who have less than 95% adherence the major barrier for the adherence were busy in work and lack of knowledge of ART. Among the patients who never missed to take the pills, 52% reported that watch was useful to recall drug taking time and 27.4% family helped them to take the pills regularly.
Patients residing in the terai (ART site of Dhangadhi and Mahendranagar) area are more than thrice likely to report adherence than the client residing at the hilly area(ART site of Accham and Doti) (OR: 2.86, 1.10-7.47).
Married were not different in their reported adherence compared to never married patients (OR: 5.61, 0.53-69.61).
Among the adherent group, 98.5% belong to the Chhetri community and 2% were from other religions. For the analysis, brahmins, chettri were placed in the advantaged group and other caste were placed in the disadvantaged group however, there was no difference in the reported adherence between these two groups (OR: 1.07, 0.45-2.51). Literate patients were more adherent to the regimen than the illiterate ones with 53% and 47% respectively. However, no significant association was found between the education status and adherence (OR: 1.46, 0.57-3.76).
Patients reported of prior alcohol habit were around 4.5 times less likely to adhere to the ART. Significant association was observed between the Prior alcohol habit and reported adherence rate (OR: 4.5, 1.547-12.79). Similarly the prior smoking habit was associated with the reported adherence (OR: 3.5, 1.33-9.45). No association was observed between the current alcohol habit and adherence to treatment (OR: 1. habit and adherence to treatment was not associated with adherence to treatment (OR: 0.43, 0.95-1.962). Around 76% of the client reporting higher adherence belongs to the single family and only 24% of the client reporting adherent belonged to joint family (Table 2) . Those patients who had to pay less than 2$ per visit were around 10 times more likely to adhere to the treatment therapy than those who had to pay more than 2$ per visit (OR: 9.84, 3.44-28.73).
For around 85% of the patients service provided was excellent ('Yes' to more than 5 health facility related statements), whereas 15% responded that the service was not good. The patients who are very satisfied with the services were 13.1 times more likely to adhere to the ART. A significant association was observed between the adherence and patient satisfaction (OR: 13.1, 4.75-36.19). Patients who experience the side effects (72%) are found to be more non-adherent than those patients who did not experience any form of side effects (8%). The relation observed was non-significant (OR; 2.71, 0.85-5.55). Among the patients who experienced the side effects, majority (14.2%) of the patients reported dizziness and headache. Similarly, 10.5% reported arthritis and around 4.5% reported diarrhoea and 4.1% reported of anaemia (Table 3 ).
Discussion
The overall adherence rate for 1 month was found to be 84% which is similar to those reported from India 8 suggests that patients would benefit if ART services were available in more institutions located closer to beneficiaries' homes. Study of Botswana reported that adherence difficulties related to the financial demands of therapy and an inability to afford medicines for varying periods. 19 Access to the antiretroviral therapy was a predominant predictor of the adherence rate among the patients. Patients residing at the Terai belts with easy access to transportation and health facility were significantly associated with better adherence than that of client residing at the hilly areas with difficult terrain and longer distance from the health facility.
Interlinked with the area of residence is the travel cost associated with the visit to the health facility. A significant association was found between the travel cost and poor adherence. Financial burden was also reported to be a major reason for non adherence in India. 8 Studies conducted in Africa 26 reveal that the cost of medication is one of the most significant barriers to treatment adherence. In Botswana 19 , it was also reported that adherence difficulties related to the financial demands of therapy and an inability to afford medicines for varying periods. Though Antiretroviral Therapy is provided free of cost in Nepal 10 , clinic visits cost money which may stretch an already meagre budget, thus increasing the likelihood of missing the pills in lack of travel cost in resource-poor countries like Nepal.
Prior alcohol and smoking habits was associated with poor adherence similar to that of Ethiopia. 18 Alcohol and smoking habit adversely affect person's ability and skills in adhering to the treatment in both the studies. Disclosure of their HIV status is associated with the better adherence. Social or family support, peer interaction, and better physical interactions and relationships are characteristics of patients who achieve optimal adherence. 17 Social and family support, peer interaction, better physical interactions and relationship is achieved only when the client discloses his/her status. Studies 27 suggest that people cope better, if they share their HIV status. Moreover, once disclosed they usually do not fear to take drugs at the scheduled time which may have helped in improving their adherence. Support group on ARV therapy should be organized for people living with HIV and AIDS to enable discussion of disclosure, psychological issue and barrier to adherence.
Being away from home, forgetting, being too busy, stigma attached to ARVs, side effects, feeling sick were found as the most common reason for missing the pills which were almost identical to those found in other studies 14 ; Several studies 15 have shown that being away from home, being too busy and forgetting is closely interrelated. Use of reminders such as the watch, mobiles and other electronic devices facilitated to take the pills regularly and timely among the client with optimal adherence. So, provision of such reminders can help in achieving optimal adherence.
Conclusions
The adherence 84% seems to be encouraging; however achieving adherence for all the patients on ART is a great challenge. Disclosure of the HIV status by the client, perceived benefit of the treatment, satisfaction from the service provider was found to be the facilitator for the adherence. Factors such as the prior alcohol and smoking habit, topographical difficulties and most importantly the financial cost associated with medications was identified as the barriers to the antiretroviral therapy.
Timely detection of non-adherence behaviours and appropriate monitoring of patients' difficulties with ART could potentially help patients to maintain adherence and therefore improve the treatment outcomes. Adherence is a process, not a single event, and adheren ce support must, therefore, be integrated into regular clinical follow up. Investigation of factors related with long-term adherence would require longer follow-up than the present study.
In order to maximize the benefit of ART, patients should be educated on the need of adhering to the right dose at the right time as an intervention against barriers to adherence. We suggest further research should investigate the cause of disparity in adherence between refill and time of taking ARV drugs, utilization of multiple measures of adherence to be incorporated in the care plans and multiple-target interventions focused to resolve the barriers to adherence should be implemented based on barriers present.
Government's initiatives towards financial and moral support to PLHA should be promoted to overcome the financial barrier and optimize the treatment adherence. Further study should be carried out to fill the gap. Future studies should be conducted for better understanding and interventions.
